Trial Profile
A pilot study of the effects of a single high dose bolus tirofiban in diabetic patients undergoing elective percutaneous coronary intervention
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 16 Dec 2006 New trial record.